Effect of CAIPaDi from visit 1 to visit 7 in diabetes control variables, October 2013 – August 2018
| Variable | Parameter | Goal (%) | Basal (visit 1) | 3-year follow-up (visit 7) | Change in percentage points |
| Patients n=238 (%) | Patients n=238 (%) | ||||
| Glycated hemoglobin (%) | >9.0 | ≤15 | 50 (21) | 21 (9) | −12 |
| 7.0%–9.0 | >60 | 62 (26) | 62 (26) | 0 | |
| <7.0 | >40 | 126 (53) | 155 (65) | 12 | |
| Blood pressure (mm Hg) | ≥140/90 | ≤35 | 12 (4) | 6 (3) | −2 |
| <130/80 | >25 | 102 (43) | 179 (7) | 32 | |
| LDL-c (mg/dL) | ≥130 | ≤37 | 76 (34) | 40 (17) | −15 |
| HDL-c (mg/dL) | <100 | 238 (100) | 238 (100) | 0 | |
| Triglyceride (mg/dL) | ≤150 | – | 97 (41) | 138 (58) | 17 |
| Albumin/creatinine ratio (mg/g) | <30 | – | 204 (86) | 195 (82) | −4 |
| BMI (kg/m2)—normal | <25 | – | 38 (16) | 47 (20) | 4 |
| Overweight | (25–29.9) | – | 112 (47) | 103 (43) | −4 |
| Obesity level I | (30–34.9) | – | 68 (29) | 70 (29) | 1 |
| Obesity level II | (35–39.9) | – | 14 (6) | 18 (8) | 2 |
| Obesity level III | ≥40 | – | 6 (3) | 0 (0) | −3 |
Percentages may not add up to 100% due to rounding. The goal refers to the expected percentage of patients in the value defined in the parameter column.
All the clinical outcomes are not reported but they are available from the authors on request. There were no hospitalizations for severe hypoglycemia.
BMI, body mass index; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol.